share_log

Unicycive Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Vivo Opportunity Fund Holdings, L.P.(9.99%),Vivo Opportunity, LLC(9.99%)

Unicycive Therapeutics | SC 13G:超过5%持股股东披露文件-Vivo Opportunity Fund Holdings, L.P.(9.99%),Vivo Opportunity, LLC(9.99%)

SEC announcement ·  2023/07/14 16:30
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息